104
Views
1
CrossRef citations to date
0
Altmetric
Device Evaluation

IonicRF™: a Novel Step in Technology for Radiofrequency Ablation Treatments

ORCID Icon, &
Pages 21-27 | Received 11 Jul 2021, Accepted 03 Dec 2021, Published online: 10 Jan 2022
 

Abstract

Radiofrequency ablation (RFA) has been utilized since the 1970s to treat various painful conditions. The technology has evolved from its initial use to treat lumbar facet mediated pain with monopolar lesioning to now treat a plethora of chronic pain conditions. This article reviews Abbott Corporation’s (IL, USA) IonicRF™ generator. The IonicRF generator utilizes an intelligent power algorithm that improves efficiency and reduces procedure time. The generator also carries a wide range of RFA therapies such as monopolar, bipolar, pulsed or pulsed dose radiofrequency. Additionally, the IonicRF RFA generator is compatible with the Simplicity™ RF probe (Abbott) which allows for efficient and effective denervation of the sacroiliac joint.

Lay abstract

Radiofrequency ablation (RFA) has been utilized since the 1970s to treat many different painful conditions. The technique was originally developed to treat common low back pain because of arthritis. Since that time, RFA has evolved to treat other painful areas of the body such as the face, knees, shoulders, hips and buttocks. RFA is a safe, convenient, and non-surgical option to treat pain in these different areas of the body. This technique is reserved for patients who have already tried physical therapy and over the counter pain medications such as ibuprofen and acetaminophen.

Financial & competing interests disclosure

JE Pope is a consultant for Abbott. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.